Abbott Laboratories News

Wedbush Pac Grow initiated coverage of the health-care firm at Outperform. Abbott Laboratories By Wedbush Pac Grow Life Sciences WE ARE INITIATING COVERAGE of Abbott Laboratories with an Outperform rating.

Abbott Laboratories this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat bipolar disorder and epilepsy, are under federal investigation.

Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnsona s Centocor unit in a suit over an arthritis drug patent.

29 | Founder, CEO | Groupon Inc. | Chicago For someone with a life goal no less lofty than "changing the world," Andrew Mason doesn't seem to take himself too seriously. When he found out that his company, Groupon, was up against Abbott Laboratories for a Chicago Innovation people's choice award, ...

In 2001, Lillie Greene's life was turned upside down. Her son, not knowing he was diabetic, suffered an aneurysm and went into a coma for 32 days.

Abbott Park, Illinois - Abbott announced today that it has received the annual Illinois Continuous Improvement Award for environmental excellence.

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICORA tablets, 48 mg and 145 mg.

Rob McIver, co-manager of the Jensen Fund , says long-term investing success means selecting high-quality securities, such as Abbott Laboratories and Adobe .

Abbott Laboratories has opened its Abbott Nutrition facility at the Research Park on the University of Illinois campus.

Ilhavo, Portugal a ' 20/10/2009 a ' SADIF Investment Analytics, announces a new summary due diligence report covering Abbott Laboratories .

Global pharmaceutical companies Baxter International Incorporated : and Abbott Laboratories : this week reported earnings for the third quarter of their 2009 fiscal years.

Abbott Laboratories said third quarter earnings surged by more than a third, to $1.48 billion, or 95 cents per share.

Abbott Laboratories led drug stocks into positive territory Wednesday, as shares of the conglomerate gained in the wake of a better-than-expected third-quarter earnings report.

Abbott Laboratories says it beat its own expectations in the third quarter as sales of its drug Humira continued to climb, as did sales of medical products and nutritional products for children.

A surprisingly strong profit and outlook from Intel and much stronger-than-forecast results from J.P. Morgan Chase sent U.S. stock futures rallying Wednesday and put a 10,000 level on the Dow Jones Industrial Average within reach.

Among the companies whose shares are expected to see active trade in Wednesday's session are J.P. Morgan Chase & Co., Abbott Laboratories and Host Hotels & Resorts Inc.

Filed under: Newsletters , Abbott Laboratories , Baxter Intl , Bristol-Myers Squibb , Gilead Sciences , Stocks to Buy "Being contrarians, we are always looking for laggard stocks with the potential to rebound," says turnaround expert George Putnam .

Drug and medical-device company Abbott Laboratories is scheduled to report earnings for the third quarter on Wednesday.

Durham advertising agency McKinney has snared yet another new account: EAS, the sports nutrition brand that is part health care giant Abbott Laboratories.

Below is my list of the top ten dividend-paying stocks to consider for purchase.